Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Arthur J. Gallagher & Co. heads into its October 29 results with a cluster of analyst target cuts arriving all at once and a stock that has already shed 12.5% over the past month to $229.85.
The Street story this week is unambiguous: everybody is cutting, but nobody is leaving. Morgan Stanley moved first on October 6, trimming its Overweight target to $260 from $285, a second reduction in two weeks after an earlier cut from $290 on September 25. Mizuho followed on October 7, lowering to $271 from $292 while holding Outperform. Cantor Fitzgerald cut to $280 from $300, keeping Neutral. Further back in September, RBC and Wells Fargo also trimmed while maintaining positive ratings. The mean consensus target now sits at roughly $286, implying around 24% return potential from current levels. That is a wide gap relative to the stock price, reflecting both the recent drawdown and the fact that no firm has downgraded the rating itself. Bulls point to AJG's organic growth engine and disciplined acquisition cadence in specialty and wholesale brokerage. Bears flag the risk that M&A integration costs and softer commercial lines pricing could crimp margins. The forward earnings picture, however, looks unusually strong on paper: the twelve-month forward EPS growth factor ranks in the 98th percentile of the universe, though the EPS surprise factor is weak at the 12th percentile, a gap that will be squarely in focus on October 29. The PE multiple has compressed almost 2.4 points over the past month to around 15.9x, while the dividend score ranks in the 91st percentile.
Short positioning is low and not the story here. Short interest is running at 2.5% of the free float, up about 4.5% on the week in share terms but down 2% on the month. The lending market is loose: availability is around 702%, meaning there are roughly seven shares available to borrow for every one already borrowed, comfortably above the 52-week low of 676%. The cost to borrow is negligible at 0.5%. None of this suggests any squeeze dynamic or unusual short-seller conviction. Options positioning has actually shifted more constructive than usual. The put/call ratio has fallen to 0.36, more than one standard deviation below its 20-day mean of 0.42 and near its 52-week low of 0.33. Call activity is dominating, consistent with a market that is not bracing for further sharp downside despite the recent sell-off.
Institutional ownership tells a broadly stable story. BlackRock holds 7.7% and added 515,000 shares in the most recent period. Capital Research added over 700,000 shares. JPMorgan Asset Management added about 191,000. Fidelity's position is large at 6.5% but the data is from July. JPMorgan Chase & Co. filed a 13G/A in July disclosing its stake had fallen from 7.8% to 5.5%, the one clear trim among the major holders. No 13D activist is on the register, and there are no activist flags on this name.
Insider activity over the past 90 days has run at a net negative of around 28,500 shares, worth roughly $7.6 million. The open-market activity is thin: the CAO sold 1,000 shares on September 15 at $252.86 without a 10b5-1 plan, a modest discretionary sale. The other activity involves option exercises paired with same-day open-market sales, which are compensation mechanics rather than conviction trades. The CEO filed a gift transaction on September 8, transferring nearly 50,000 shares, which similarly carries no directional signal.
The earnings history adds a note of caution. The July 30 print produced a one-day decline of 7.2% and the stock was still down 6.4% five days later, a pattern that investors will remember heading into October 29. Wikipedia attention for AJG is running about 1.8 standard deviations below its own 90-day average, suggesting retail interest in the name has faded rather than built into the upcoming print. Close peers BRO and AON were both roughly flat on the week, while RYAN added 1.2%, making AJG's own 0.9% weekly gain look broadly in line with the group.
What to watch next: whether the October 29 print can close the gap between the 98th-percentile forward EPS growth score and the 12th-percentile EPS surprise history, and how management characterises M&A pipeline activity against a backdrop where the Street has reset targets lower but kept its buy ratings intact.
See the live data behind this article on ORTEX.
Open AJG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
